The International Research Conference Aims and Objectives
The International Research Conference is a federated organization dedicated to bringing together a significant number of diverse scholarly events for presentation
within the conference program. Events will run over a span of time during the conference depending on the number and length of the presentations.
With its high quality, it provides an exceptional value for students, academics and industry researchers.
International Conference on Molecular Oncology and Immunology
aims to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of
Molecular Oncology and Immunology.
It also provides a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent innovations,
trends, and concerns as well as practical challenges encountered and solutions adopted in the fields of Molecular Oncology and Immunology.
Call for Contributions
Prospective authors are kindly encouraged to contribute to and help shape the conference through submissions of their research abstracts, papers and e-posters.
Also, high quality research contributions describing original and unpublished results of conceptual, constructive, empirical, experimental, or
theoretical work in all areas of Molecular Oncology and Immunology are cordially invited for presentation at the conference.
The conference solicits contributions of abstracts, papers and e-posters that address themes and topics of the conference, including figures, tables and references of
novel research materials.
Guidelines for Authors
Please ensure your submission meets the conference's strict guidelines for accepting scholarly papers.
Downloadable versions of the check list for
Full-Text Papers and
Abstract Papers.
Please refer to the
Paper Submission Guideline,
Abstract Submission Guideline and
Author Information
before submitting your paper.
Conference Proceedings
All submitted conference papers will be blind peer reviewed by three competent reviewers.
The peer-reviewed conference proceedings are indexed in the Open Science Index,
Google Scholar,
Semantic Scholar,
Zenedo,
BASE,
WorldCAT,
Sherpa/RoMEO,
and other index databases. Impact Factor Indicators.
Special Journal Issues
20. International Conference on Molecular Oncology and Immunology has teamed up with the Special Journal Issue on
Molecular Oncology and Immunology.
A number of selected high-impact full text papers will also be considered for the special journal issues.
All submitted papers will have the opportunity to be considered for this Special Journal Issue.
The paper selection will be carried out during the peer review process as well as at the conference presentation stage.
Submitted papers must not be under consideration by any other journal or publication.
The final decision for paper selection will be made based on peer review reports by the Guest Editors and the Editor-in-Chief jointly.
Selected full-text papers will be published online free of charge.
Conference Sponsor and Exhibitor Opportunities
The Conference offers the opportunity to become a conference sponsor or exhibitor.
To participate as a sponsor or exhibitor, please download and complete the
Conference Sponsorship Request Form.
Selected Papers
-
The Role of Mobile Technology in Surveillance of Adverse Events Following Immunization during New Vaccines Introduction in Cameroon: A Cross-Sectional Study
A. A. Njoh, S. T. Ndoula, A. Adidja, G. N. Menan, A. Mengue, E. Mboke, H. B. Bachir, S. C. Nchinjoh, L. Adisso, Y. Saidu, L. Cleenewerck de Kiev
-
Assessment of the Efficacy of Oral Vaccination of Wild Canids and Stray Dogs against Rabies in Azerbaijan
E. N. Hasanov, K. Y. Yusifova, M. A. Ali
-
Comparison of the Use of Vaccines or Drugs against Parasitic Diseases
H. Al-Khalaifa, A. Al-Nasser
-
Identification of Promiscuous Epitopes for Cellular Immune Responses in the Major Antigenic Protein Rv3873 Encoded by Region of Difference 1 of Mycobacterium tuberculosis
Abu Salim Mustafa
-
Displaying of GnRH Peptides on Bacteriophage T7 and Its Immunogenicity in Mice Model
Hai Xu, Yiwei Wang, Xi Bao, Bihua Deng, Pengcheng Li, Yu Lu
-
The Need for Including Hepatitis a Vaccine in Routine Childhood Immunization Programs in Europe as a Response to the Influx of Refugees from the Middle East and North Africa (MENA) Regions
S. Ramia, N. Melhem, K. Kreidieh
-
Vaccinated Susceptible Infected and Recovered (VSIR) Mathematical Model to Study the Effect of Bacillus Calmette-Guerin (BCG) Vaccine and the Disease Stability Analysis
Muhammad Shahid, Nasir-uddin Khan, Mushtaq Hussain, Muhammad Liaquat Ali, Asif Mansoor
-
Hepatitis B Virus Infection among Egyptian Children Vaccinated during Infancy
Iman I. Salama, Samia M. Sami, Somaia I. Salama, Zeinab N. Said, Thanaa M. Rabah, Aida M. Abdel-Mohsin
-
Unnoticeable Mumps Infection in India: Does MMR Vaccine Protect against Circulating Mumps Virus Genotype C?
Jeevan Malayan, Aparna Warrier, Padmasani Venkat Ramanan, Sanjeeva Reddy N, Elanchezhiyan Manickan
-
The Influence of Heat Treatment on Antimicrobial Proteins in Milk
Jelena Zagorska, Inga Ciprovica
-
Immune Responce in Mice Immunized with Live Cold-Adapted Influenza Vaccine in Combination with Chitosan-Based Adjuvants
Nelly К. Akhmatova, Оlga V. Lebedinskaya, Ancha V. Baranova, Еlena А. Lebedinskaya,
Ekaterina V. Sorokina, Elvin А. Akhmatov, Аnatoliy P. Godovalov, Stanislav G. Markushin
-
Chitosan Nanoparticle as a Novel Delivery System for A/H1n1 Influenza Vaccine: Safe Property and Immunogenicity in Mice
Nguyen Anh Dzung, Nguyen Thi Ngoc Hà, Dang Thi Hong Van, Nguyen Thi Lan Phuong, Nguyen Thi
Nhu Quynh, Dinh Minh Hiep, Le Van Hiep
-
Implementation of a “DIVA“ Concept withspecific Elisa Kits; When Subunit H5 Avian Influenza Vaccine is used
Robles F, Uribe A, Guadarrama A , Castellanos L, González C.
Conference venue information will be released soon.
Immunogenetics
Molecular oncology and immunology
Innate immune system
Immunopathogenesis
Immunomicrobiology
Immunoglobulins
Immunoglycomics
Immunoproteomics
Immunoprophylaxis
Molecular vaccines
Antibody engineering
Cancer vaccines
Cancer stem cell therapy
Drug therapies
Cancer immunotherapy
T-cell immunology
Allergy immunology
HIV immunology
Parasite immunology
Lymphokines and cytokines
Thymus and lymphocyte immunobiology
Systemic lupus erythmatosus
Abstracts/Full-Text Paper Submission Deadline |
|
February 13, 2025 |
Notification of Acceptance/Rejection |
|
February 27, 2025 |
Final Paper (Camera Ready) Submission & Early Bird Registration Deadline |
|
March 25, 2026 |
Conference Dates |
|
July 26-27, 2026 |